File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1006/bbrc.1996.0621
- Scopus: eid_2-s2.0-0030008229
- PMID: 8619881
- WOS: WOS:A1996UF91100047
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Bioassay of endothelium-derived hyperpolarizing factor
Title | Bioassay of endothelium-derived hyperpolarizing factor |
---|---|
Authors | |
Issue Date | 1996 |
Publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/wps/find/journaldescription.cws_home/622790/description |
Citation | Biochemical And Biophysical Research Communications, 1996, v. 221 n. 2, p. 484-488 How to Cite? |
Abstract | Endothelium-derived hyperpolarizing factor (EDHF) mediates vasodilatation in certain blood vessels, together with prostacyclin and NO. However, its chemical nature is not known. A perfusion-superfusion cascade was developed to confirm the diffusible nature of EDHF. Canine carotid arteries with endothelium were used as donors of vasoactive substances, whereas rings of coronary artery without endothelium were used as detectors. Inhibitors of NO synthesis and cyclooxygenase were present throughout, to avoid interference from NO and prostanoids. Measurements of membrane potential and isometric tension, in coronary arteries without endothelium (used as detectors), demonstrated the release of EDHF from the carotid arteries, following treatment with 8-methoxypsoralen, bradykinin and thimerosal. The K+-channel blocker tetraethylammonium inhibited the action of EDHF in the detectors. Thus, these results demonstrate that endothelial cells release a diffusible activator of K+-channels in vascular smooth muscle. |
Persistent Identifier | http://hdl.handle.net/10722/171186 |
ISSN | 2023 Impact Factor: 2.5 2023 SCImago Journal Rankings: 0.770 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mombouli, JV | en_US |
dc.contributor.author | Bissiriou, I | en_US |
dc.contributor.author | Agboton, VD | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:12:35Z | - |
dc.date.available | 2012-10-30T06:12:35Z | - |
dc.date.issued | 1996 | en_US |
dc.identifier.citation | Biochemical And Biophysical Research Communications, 1996, v. 221 n. 2, p. 484-488 | en_US |
dc.identifier.issn | 0006-291X | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171186 | - |
dc.description.abstract | Endothelium-derived hyperpolarizing factor (EDHF) mediates vasodilatation in certain blood vessels, together with prostacyclin and NO. However, its chemical nature is not known. A perfusion-superfusion cascade was developed to confirm the diffusible nature of EDHF. Canine carotid arteries with endothelium were used as donors of vasoactive substances, whereas rings of coronary artery without endothelium were used as detectors. Inhibitors of NO synthesis and cyclooxygenase were present throughout, to avoid interference from NO and prostanoids. Measurements of membrane potential and isometric tension, in coronary arteries without endothelium (used as detectors), demonstrated the release of EDHF from the carotid arteries, following treatment with 8-methoxypsoralen, bradykinin and thimerosal. The K+-channel blocker tetraethylammonium inhibited the action of EDHF in the detectors. Thus, these results demonstrate that endothelial cells release a diffusible activator of K+-channels in vascular smooth muscle. | en_US |
dc.language | eng | en_US |
dc.publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/wps/find/journaldescription.cws_home/622790/description | en_US |
dc.relation.ispartof | Biochemical and Biophysical Research Communications | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Biological Assay | en_US |
dc.subject.mesh | Biological Factors - Metabolism | en_US |
dc.subject.mesh | Bradykinin - Pharmacology | en_US |
dc.subject.mesh | Carotid Arteries - Drug Effects - Metabolism - Physiology | en_US |
dc.subject.mesh | Coronary Vessels - Drug Effects - Metabolism - Physiology | en_US |
dc.subject.mesh | Dogs | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Membrane Potentials | en_US |
dc.subject.mesh | Methoxsalen - Pharmacology | en_US |
dc.subject.mesh | Muscle Relaxation | en_US |
dc.subject.mesh | Thimerosal - Pharmacology | en_US |
dc.title | Bioassay of endothelium-derived hyperpolarizing factor | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1006/bbrc.1996.0621 | en_US |
dc.identifier.pmid | 8619881 | - |
dc.identifier.scopus | eid_2-s2.0-0030008229 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0030008229&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 221 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.spage | 484 | en_US |
dc.identifier.epage | 488 | en_US |
dc.identifier.isi | WOS:A1996UF91100047 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Mombouli, JV=7004285772 | en_US |
dc.identifier.scopusauthorid | Bissiriou, I=8052855800 | en_US |
dc.identifier.scopusauthorid | Agboton, VD=8052855900 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0006-291X | - |